Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
暂无分享，去创建一个
[1] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[2] Bret Larget,et al. Analysis of Categorical Data , 2002 .
[3] U Chakravarthy,et al. Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? , 2000, The British journal of ophthalmology.
[4] R Birngruber,et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. , 1999, Archives of ophthalmology.
[5] P. Kaiser. Photodynamic therapy with verteporfin for choroidal neovascularization , 2000 .